Abstract
Does serotyping for an extended anti-citrullinated peptide autoantibody panel add value to CCP2 testing in the diagnosis of RA amongst early undifferentiated arthritis patients?
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have